These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 24866238
1. MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes. Lang Y, Xu S, Ma J, Wu J, Jin S, Cao S, Yu Y. Biochem Biophys Res Commun; 2014 Jul 18; 450(1):154-9. PubMed ID: 24866238 [Abstract] [Full Text] [Related]
2. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer. He D, Wang J, Zhang C, Shan B, Deng X, Li B, Zhou Y, Chen W, Hong J, Gao Y, Chen Z, Duan C. Mol Cancer; 2015 Apr 01; 14():73. PubMed ID: 25889562 [Abstract] [Full Text] [Related]
3. MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB. Yongchun Z, Linwei T, Xicai W, Lianhua Y, Guangqiang Z, Ming Y, Guanjian L, Yujie L, Yunchao H. Cancer Lett; 2014 May 28; 347(1):65-74. PubMed ID: 24486218 [Abstract] [Full Text] [Related]
4. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells. Yu QQ, Wu H, Huang X, Shen H, Shu YQ, Zhang B, Xiang CC, Yu SM, Guo RH, Chen L. Biomed Pharmacother; 2014 Mar 28; 68(2):155-61. PubMed ID: 24486107 [Abstract] [Full Text] [Related]
5. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C. Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y. Eur J Cancer; 2014 Sep 28; 50(13):2336-50. PubMed ID: 25001183 [Abstract] [Full Text] [Related]
6. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, Yang GH. Clin Chim Acta; 2010 Jun 03; 411(11-12):846-52. PubMed ID: 20223231 [Abstract] [Full Text] [Related]
7. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC. Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C, Zhang C. J Exp Clin Cancer Res; 2016 May 10; 35():76. PubMed ID: 27164951 [Abstract] [Full Text] [Related]
9. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN. Xie X, Liu HT, Mei J, Ding FB, Xiao HB, Hu FQ, Hu R, Wang MS. Int J Clin Exp Pathol; 2015 May 10; 8(4):3827-34. PubMed ID: 26097565 [Abstract] [Full Text] [Related]
11. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN. Lei L, Huang Y, Gong W. Oncol Rep; 2013 Dec 10; 30(6):2897-902. PubMed ID: 24084898 [Abstract] [Full Text] [Related]
13. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer. Xu W, Hang M, Yuan CY, Wu FL, Chen SB, Xue K. Int J Clin Exp Pathol; 2015 Dec 10; 8(4):3864-70. PubMed ID: 26097570 [Abstract] [Full Text] [Related]
14. MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer. Huang T, She K, Peng G, Wang W, Huang J, Li J, Wang Z, He J. Int J Oncol; 2016 Oct 10; 49(4):1437-44. PubMed ID: 27498924 [Abstract] [Full Text] [Related]
16. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Shang Y, Zang A, Li J, Jia Y, Li X, Zhang L, Huo R, Yang J, Feng J, Ge K, Yang Y, Zhang Y, Jiang J. Biomed Pharmacother; 2016 Oct 10; 83():1175-1181. PubMed ID: 27551765 [Abstract] [Full Text] [Related]
18. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9. Wang FF, Wang S, Xue WH, Cheng JL. Mol Cell Biochem; 2016 Dec 10; 423(1-2):29-37. PubMed ID: 27770372 [Abstract] [Full Text] [Related]
19. GAS5 knockdown reduces the chemo-sensitivity of non-small cell lung cancer (NSCLC) cell to cisplatin (DDP) through regulating miR-21/PTEN axis. Cao L, Chen J, Ou B, Liu C, Zou Y, Chen Q. Biomed Pharmacother; 2017 Sep 10; 93():570-579. PubMed ID: 28686971 [Abstract] [Full Text] [Related]
20. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer. Zhang Z, Yang Y, Zhang X. Life Sci; 2017 Nov 01; 188():163-171. PubMed ID: 28882645 [Abstract] [Full Text] [Related] Page: [Next] [New Search]